Correlation Between Protara Therapeutics and Puma Biotechnology

Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protara Therapeutics and Puma Biotechnology, you can compare the effects of market volatilities on Protara Therapeutics and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and Puma Biotechnology.

Diversification Opportunities for Protara Therapeutics and Puma Biotechnology

0.54

Correlation Coefficient

Protara Therapeutics  Puma Biotechnology

Very weak diversification

The 3 months correlation between Protara and Puma is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and Puma Biotechnology go up and down completely randomly.

Pair Corralation between Protara Therapeutics and Puma Biotechnology

Given the investment horizon of 90 days Protara Therapeutics is expected to generate 2.35 times more return on investment than Puma Biotechnology. However, Protara Therapeutics is 2.35 times more volatile than Puma Biotechnology. It trades about 0.22 of its potential returns per unit of risk. Puma Biotechnology is currently generating about 0.09 per unit of risk. If you would invest  188.00  in Protara Therapeutics on September 13, 2024 and sell it today you would earn a total of  437.00  from holding Protara Therapeutics or generate 232.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Protara Therapeutics  vs.  Puma Biotechnology

Protara Therapeutics

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Protara Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Protara Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Puma Biotechnology

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Protara Therapeutics and Puma Biotechnology

The main advantage of trading using opposite Protara Therapeutics and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.

The idea behind Protara Therapeutics and Puma Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.